BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14648736)

  • 41. The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
    Predović J; Balog T; Marotti T; Gabrić N; Bohac M; Romac I; Dekaris I
    Coll Antropol; 2008 Oct; 32 Suppl 2():15-9. PubMed ID: 19138000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
    Ogawa M; Ikeuchi K; Watanabe M; Etoh K; Kobayashi T; Takao Y; Anazawa S; Yamazaki Y
    Hepatogastroenterology; 2005; 52(63):875-80. PubMed ID: 15966224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
    Volman TJ; Goris RJ; Lomme RM; DeGroot J; Verhofstad AA; Hendriks T
    J Pathol; 2004 Aug; 203(4):968-75. PubMed ID: 15259001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis.
    Kim YW; Ko YT; Kim NK; Chung HC; Min BS; Lee KY; Park JP; Kim H
    Scand J Gastroenterol; 2010; 45(2):217-25. PubMed ID: 20095886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
    Makowski GS; Ramsby ML
    Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.
    Morán A; Iniesta P; García-Aranda C; De Juan C; Díaz-López A; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Balibrea JL; Benito M
    Oncol Rep; 2005 Jan; 13(1):115-20. PubMed ID: 15583811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
    van der Jagt MF; Sweep FC; Waas ET; Hendriks T; Ruers TJ; Merry AH; Wobbes T; Span PN
    Cancer Lett; 2006 Jun; 237(2):289-97. PubMed ID: 16046057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
    Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
    Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of matrix metalloproteinase (MMP)-2 and MMP-9 in canine seminal plasma.
    Saengsoi W; Shia WY; Shyu CL; Wu JT; Warinrak C; Lee WM; Cheng FP
    Anim Reprod Sci; 2011 Aug; 127(1-2):114-9. PubMed ID: 21824735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer.
    Bogusiewicz M; Stryjecka-Zimmer M; Szymanski M; Rechberger T; Golabek W
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):132-6. PubMed ID: 12574771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
    Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G
    Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
    Bredin CG; Liu Z; Klominek J
    Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues.
    Choudhary S; Higgins CL; Chen IY; Reardon M; Lawrie G; Vick GW; Karmonik C; Via DP; Morrisett JD
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2351-8. PubMed ID: 16888239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells.
    Hwang ES; Lee HJ
    J Nutr Biochem; 2006 Dec; 17(12):837-46. PubMed ID: 16563723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.